These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26629827)

  • 1. Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate.
    Zwolak A; Szuster-Ciesielska A; Daniluk J; Słabczyńska O; Kandefer-Szerszeń M
    PLoS One; 2015; 10(12):e0143851. PubMed ID: 26629827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin Changes the Relationship between Blood Monocyte Toll-Like Receptor 4 Levels and Nonalcoholic Fatty Liver Disease-Ex Vivo Studies.
    Zwolak A; Słabczyńska O; Semeniuk J; Daniluk J; Szuster-Ciesielska A
    PLoS One; 2016; 11(3):e0150233. PubMed ID: 26930651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease.
    Arias-Loste MT; Iruzubieta P; Puente Á; Ramos D; Santa Cruz C; Estébanez Á; Llerena S; Alonso-Martín C; San Segundo D; Álvarez L; López Useros A; Fábrega E; López-Hoyos M; Crespo J
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD.
    du Plessis J; Korf H; van Pelt J; Windmolders P; Vander Elst I; Verrijken A; Hubens G; Van Gaal L; Cassiman D; Nevens F; Francque S; van der Merwe S
    PLoS One; 2016; 11(12):e0166048. PubMed ID: 27992443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exenatide ameliorates experimental non-alcoholic fatty liver in rats via suppression of toll-like receptor 4/NFκB signaling: Comparison to metformin.
    Saad ZA; Khodeer DM; Zaitone SA; Ahmed AAM; Moustafa YM
    Life Sci; 2020 Jul; 253():117725. PubMed ID: 32348835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic TLR4 signaling in obese NAFLD.
    Sharifnia T; Antoun J; Verriere TG; Suarez G; Wattacheril J; Wilson KT; Peek RM; Abumrad NN; Flynn CR
    Am J Physiol Gastrointest Liver Physiol; 2015 Aug; 309(4):G270-8. PubMed ID: 26113297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and metabolic characterization of obese subjects without non-alcoholic fatty liver: A targeted metabolomics approach.
    Feldman A; Eder SK; Felder TK; Paulweber B; Zandanell S; Stechemesser L; Schranz M; Strebinger G; Huber-Schönauer U; Niederseer D; Patsch W; Weghuber D; Tevini J; Datz C; Aigner E
    Diabetes Metab; 2019 Apr; 45(2):132-139. PubMed ID: 30266576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
    Aragonès G; Auguet T; Berlanga A; Guiu-Jurado E; Martinez S; Armengol S; Sabench F; Ras R; Hernandez M; Aguilar C; Colom J; Sirvent JJ; Del Castillo D; Richart C
    PLoS One; 2016; 11(4):e0154601. PubMed ID: 27123846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialyzable leukocyte extract differentially regulates the production of TNFalpha, IL-6, and IL-8 in bacterial component-activated leukocytes and endothelial cells.
    Ojeda MO; van't Veer C; Fernández Ortega CB; Araña Rosainz Mde J; Buurman WA
    Inflamm Res; 2005 Feb; 54(2):74-81. PubMed ID: 15750714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetuin-A: a novel link between obesity and related complications.
    Trepanowski JF; Mey J; Varady KA
    Int J Obes (Lond); 2015 May; 39(5):734-41. PubMed ID: 25468829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
    du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S
    Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased production of IL-1alpha and TNF-alpha in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease.
    Poniachik J; Csendes A; Díaz JC; Rojas J; Burdiles P; Maluenda F; Smok G; Rodrigo R; Videla LA
    Cytokine; 2006 Mar; 33(5):252-7. PubMed ID: 16564703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
    Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
    Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide - induced cytokine production in monocytes of hypercholesterolemic patients.
    Moutzouri E; Tellis CC; Rousouli K; Liberopoulos EN; Milionis HJ; Elisaf MS; Tselepis AD
    Atherosclerosis; 2012 Dec; 225(2):381-7. PubMed ID: 23062767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease.
    Gangarapu V; Ince AT; Baysal B; Kayar Y; Kılıç U; Gök Ö; Uysal Ö; Şenturk H
    Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):840-5. PubMed ID: 26043290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential toll-like receptor expression after ex vivo lipopolysaccharide exposure in patients with sepsis and following surgical stress.
    Tsujimoto H; Ono S; Majima T; Efron PA; Kinoshita M; Hiraide H; Moldawer LL; Mochizuki H
    Clin Immunol; 2006 May; 119(2):180-7. PubMed ID: 16517212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining metformin therapy with caloric restriction for the management of type 2 diabetes and nonalcoholic fatty liver disease in obese rats.
    Linden MA; Lopez KT; Fletcher JA; Morris EM; Meers GM; Siddique S; Laughlin MH; Sowers JR; Thyfault JP; Ibdah JA; Rector RS
    Appl Physiol Nutr Metab; 2015 Oct; 40(10):1038-47. PubMed ID: 26394261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
    Erkan G; Sayın I; Polat FB; Çorakçı A; Ataç GK; Değertekin H
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():63-8. PubMed ID: 25910371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14.
    Ellingsen E; Morath S; Flo T; Schromm A; Hartung T; Thiemermann C; Espevik T; Golenbock D; Foster D; Solberg R; Aasen A; Wang J
    Med Sci Monit; 2002 May; 8(5):BR149-56. PubMed ID: 12011760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic intake of moderate fat-enriched diet induces fatty liver and low-grade inflammation without obesity in rabbits.
    Sigrist-Flores SC; Ponciano-Gómez A; Pedroza-González A; Gallardo-Ortíz IA; Villalobos-Molina R; Pardo-Vázquez JP; Saucedo-Campos AD; Jiménez-Flores R; Méndez-Cruz AR
    Chem Biol Interact; 2019 Feb; 300():56-62. PubMed ID: 30639268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.